Leli Zeng
- Molecular Biology top 5%
- Oncology top 1%
- Biomedical Engineering top 2%
- Materials Chemistry top 5%
- Organic Chemistry top 2%
- Topics
- Nanoplatforms for cancer theranostics (19 papers)Metal complexes synthesis and properties (15 papers)Drug Transport and Resistance Mechanisms (13 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Leli Zeng
76 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Molecular Biology 1.7k
- Oncology 1.7k
- Biomedical Engineering 1.4k
- Materials Chemistry 1.1k
- Organic Chemistry 1.0k
Countries citing papers authored by Leli Zeng
This map shows the geographic impact of Leli Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leli Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leli Zeng more than expected).
Fields of papers citing papers by Leli Zeng
This network shows the impact of papers produced by Leli Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leli Zeng. The network helps show where Leli Zeng may publish in the future.
Co-authorship network of co-authors of Leli Zeng
This figure shows the co-authorship network connecting the top 25 collaborators of Leli Zeng. A scholar is included among the top collaborators of Leli Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leli Zeng. Leli Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 17 | |
| 3 | 16 | |
| 4 | 24 | |
| 5 | Understanding and targeting resistance mechanisms in cancerbreakdown → | 177 |
| 6 | An Enzyme‐Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis‐Based Synergistic Cancer Therapybreakdown → | 323 |
| 7 | Signaling pathways and therapeutic interventions in gastric cancerbreakdown → | 167 |
| 8 | 7 | |
| 9 | 92 | |
| 10 | 17 | |
| 11 | 46 | |
| 12 | 144 | |
| 13 | 48 | |
| 14 | 11 | |
| 15 | 96 | |
| 16 | 12 | |
| 17 | 96 | |
| 18 | 114 | |
| 19 | The development of anticancer ruthenium( | 876 |
| 20 | 39 |
About Leli Zeng
Leli Zeng is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 79 papers that have together received 4.6k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (19 papers), Metal complexes synthesis and properties (15 papers) and Drug Transport and Resistance Mechanisms (13 papers). The work is most often cited by research in Oncology (1.7k citations), Cancer Research (564 citations) and Organic Chemistry (1.0k citations). Leli Zeng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhe‐Sheng Chen, Hui Chao, Liang‐Nian Ji, Pranav Gupta, Yanglu Chen, Enju Wang, Yu Chen, Yihang Pan, Chengzhi Jin and Zi‐Ning Lei. Their work appears in journals such as Chemical Society Reviews, Advanced Materials and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.